Show simple item record

FieldValueLanguage
dc.contributor.authorLeung, Sharon SY
dc.contributor.authorCarrigy, Nicholas B
dc.contributor.authorVehring, Reinhard
dc.contributor.authorFinlay, Warren H
dc.contributor.authorMorales, Sandra
dc.contributor.authorCarter, Elizabeth A
dc.contributor.authorBritton, Warwick J
dc.contributor.authorKutter, Elizabeth
dc.contributor.authorChan, Hak-Kim
dc.date.accessioned2019-05-17
dc.date.available2019-05-17
dc.date.issued2019-01-10
dc.identifier.urihttp://hdl.handle.net/2123/20427
dc.description.abstractIt was previously demonstrated that the loss of infectivity of a myovirus PEV44 after jet nebulization was closely related to a change in bacteriophage (phage) structure. In this follow-up study, we further examined the impact of jet nebulization on tailed phages, which constitute 96% of all known phages, from three different families, Podoviridae (PEV2), Myoviridae (PEV40) and Siphoviridae (D29). Transmission electron microscopy (TEM) identified major changes in phage structures after jet nebulization, correlating with their loss of infectivity. For the podovirus PEV2, jet nebulization had a negligible impact on activity (0.04 log10¬ pfu/mL loss) and structural change. On the other hand, the proportion of intact phages in the nebulised samples dropped from 50% to ~27% for PEV40 and from 15% to ~2% for D29. Phage deactivation of PEV40 measured by the TEM structural damage (0.52 log10¬ pfu/mL) was lower than that obtained by plaque assay (1.02 log10 pfu/mL), but within the range of variation (± 0.5 log10 pfu/mL). However, TEM quantification considerably underestimated the titer reduction of D29 phage, ~ 2 log pfu/mL lower than that obtained in plaque assay (3.25 log10 pfu/mL). In conclusion, nebulisation-induced titre loss was correlated with morphological damage to phages and in particular, the tail length may be an important consideration for selection of phages in inhaled therapy using jet nebulization.en_AU
dc.description.sponsorshipThis work was financially supported by the Australian Research Council (Discovery Project DP150103953). The authors acknowledge the facilities and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Australian Centre for Microscopyen_AU
dc.language.isoen_AUen_AU
dc.publisherElsevieren_AU
dc.relationARC DP150103953en_AU
dc.subjectphageen_AU
dc.subjectnebulizeren_AU
dc.subjectcryo-TEMen_AU
dc.subjectdrug-resistanceen_AU
dc.subjectpulmonary infectionsen_AU
dc.titleJet nebulization of bacteriophages with different tail morphologies – structural effectsen_AU
dc.typeArticleen_AU
dc.subject.asrcFoR::110203 - Respiratory Diseasesen_AU
dc.subject.asrcFoR::110309 - Infectious Diseasesen_AU
dc.subject.asrcFoR::111504 - Pharmaceutical Sciencesen_AU
dc.identifier.doihttps://doi.org/10.1016/j.ijpharm.2018.11.026
dc.type.pubtypePre-printen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.